B01AC22 · Blood and blood-forming organs
Prasugrel Viatris (previously Prasugrel Mylan)
Indications
Prasugrel Viatris, co administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndrome (i.e. unstable angina, non-ST segment elevation myocardial infarction [UA/NSTEMI] or ST segment elevation myocardial infarction [STEMI]) undergoing primary or delayed percutaneous coronary intervention (PCI).
Composition
- Active substance
- prasugrel besilate
- International name (INN)
- prasugrel
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Prasugrel Viatris (previously Prasugrel Mylan)
- Active substance
- prasugrel besilate
- ATC code
- B01AC22